PATENT CLAIM ANALYSIS

Application Number: 15774129
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "007400"]

Abstract:
Compositions and methods for inhibiting, treating, and/or preventing fatty acid metabolism disorders, particularly fatty acid oxidation disorders, in a subject are provided.

Claim (Index 13):
The method of  claim 12 , wherein said other therapeutic agent is triheptanoin or bezafibrate.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 93.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15590663', '14907397', '13485801', '15436247', '10557310']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.819681563341418
- 35 USC 102 Novelty (BERT): 0.6392183929609239
- Combined Prediction Score: 0.8016352463033686
- Mean Citation Score: 432.939672
- Max Citation Score: 742.03156
- Similarity Product: 533.1252309297396

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test